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The University of Sydney, New South Wales, AustraliaABSTRACT Calmodulin (CaM) expression is upregulated upon HIV-1 infection and interacts with proteins involved in viral
processing, including the multifunctional HIV-1 MA protein. We present here the results of studies utilizing small-angle neutron
scattering with contrast variation that, when considered in the light of earlier fluorescence and NMR data, show CaM binds MA in
an extended open-clamp conformation via interactions with two tryptophans that are widely spaced in sequence and space. The
interaction requires a disruption of the MA tertiary fold such that MA becomes highly extended in a long snakelike conformation.
The CaM-MA interface is extensive, covering ~70% of the length of the MA such that regions known to be important in MA inter-
actions with critical binding partners would be impacted. The CaM conformation is semiextended and as such is distinct from the
classical CaM-collapse about short a-helical targets. NMR data show that upon dissociation of the CaM-MA complex, either by
the removal of Ca2þ or increasing ionic strength, MA reforms its native tertiary contacts. Thus, we observe a high level of struc-
tural plasticity in MA that may facilitate regulation of its activities via intracellular Ca2þ-signaling during viral processing.INTRODUCTIONCalmodulin (CaM) is a ubiquitous intracellular Ca2þ
receptor that binds to hundreds of different target proteins
and modulates their activities in response to Ca2þ signals
(1,2). This relatively small (148-amino-acid) and highly
conserved eukaryotic protein thus plays a critical regulatory
role in a diverse range of essential biological functions; e.g.,
metabolism, motility, memory, immune response, apoptosis.
HIV-1 processing requires reprogramming the hosts cell
transcriptome and proteome via interactions with multiple
signaling pathways, including Ca2þ-signaling (3), and
CaM is known to interact with a number of viral proteins
involved in HIV-1 replication: including Nef (4,5),
gp160 (5–8), and MA (9,10). The nature and purpose of
these CaM interactions are not fully known, but the potential
for their playing specific roles in the viral life cycle or in
host defense mechanisms is of considerable interest.
The MA protein was first identified as a potential CaM
target from observations that CaM expression is upregulated
in cells infected with HIV-1 (9). Furthermore, CaM and
the Gag polyprotein (from which MA is derived) col-
ocalize in these cells in a distribution that is distinct
from the typical distribution of CaM in uninfected
cells. Studies using peptides from MA showed that the
N-terminal sequence of MA binds CaM in a Ca2þ-depen-
dent manner (10).Submitted March 18, 2012, and accepted for publication June 28, 2012.
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0006-3495/12/08/0541/9 $2.00The 132-amino-acid MA protein (15 kDa) is one of
several proteolytic products produced during viral pack-
aging from the Gag-polyprotein that plays a pivotal role in
HIV-1 processing (11). Before proteolytic cleavage, MA
forms the first N-terminal domain of Gag and is posttransla-
tionally modified at its amino-terminus by a myristoyl group
(12). In this form, MA directs Gag to cytoplasmic regions of
the plasma membrane enriched with negatively charged
phosphatidylinositol-(4,5)-bisphosphate (PI(4,5)P2) phos-
pholipids (13–15). The localization of Gag to the cell
membrane is mediated by the exposure of the myristoyl
group and is further enhanced by the interaction between
basic N-terminal amino acids of MA and PI(4,5)P2 (16).
This localization enables Gag to coordinate with a number
of other host-cell proteins at the inner cell membrane
to facilitate viral maturation and release. The cleaved
MA protein exists as a distinct species within the mature
HIV-1 virus and in the cytoplasm of recently infected cells
and participates in a large number of cellular processes
(17,18). It interacts with DNA and RNA, forms part of the
HIV-1 preintegration complex, and constitutes a key compo-
nent of the viral matrix, forming an icosahedral arrangement
of MA proteins that decorate the inner membrane of mature
virons.
The structures of CaM and MA have been solved by
NMR spectroscopy and x-ray crystallography. The CaM
crystal structure (19) revealed a dumbbell-shaped structure
with two globular lobes, each consisting of a pair of helix-
loop-helix motifs that form a cup-shaped domain. The sides
of the cup are formed by pairs of helices with the Ca2þ-
binding loops at the base. The inner surface is lined with
hydrophobic residues that are exposed upon Ca2þ bind-
ing via concerted motions of the helices (20) to bindhttp://dx.doi.org/10.1016/j.bpj.2012.06.042
542 Taylor et al.hydrophobic recognition sites in CaM’s regulatory targets.
The CaM Ca2þ-binding lobes are connected by an extended
a-helix that in solution has a flexible region that enables
reorientation of the lobes so that CaM can bind to diverse
target sequences (2,21–23). The crystal (24) and NMR
(25,26) structures of the MA protein each show an
N-terminal domain formed by four a-helices and three
short b-strands that sequester the amino N-terminal linked
myristoyl group (16). A fifth helix projects from the
N-terminal domain, extending into a predominantly un-
structured C-terminal tail.
We have shown previously that the Ca2þ-dependent
binding of CaM to MA induces a large conformational
change in MA involving a dramatic loss of tertiary contacts
in the unmyristoylated form (27) and Ghanam et al. (28)
confirmed this same result for the myristoylated protein.
This CaM-induced unfolding of MA could thus affect
myristoylate exposure and/or the interaction between MA
and PI(4,5)P2 at the inner cell membrane, which leads to
the intriguing possibility that Gag localization to the
membrane, or the number of the other processes MA is
involved in, could be influenced by calcium signaling. In
this regard, it is of interest to determine the overall confor-
mation of MA within the CaM-MA complex and whether
the CaM-induced unfolding of MA is reversed upon disasso-
ciation, i.e., is the unfolding of MA by CaM specific and
reversible? This question is addressed here using small-
angle neutron scattering (SANS), with deuterium labeling
and contrast variation, to determine the shapes and disposi-
tion of CaM and MA within the CaM-MA complex and
NMR spectroscopy to monitor the structural changes in
MA upon dissociation from CaM.MATERIALS AND METHODS
Sample preparation for small-angle scattering
MA and CaM were expressed in Escherichia coli and purified as described
previously in Chow et al. (27). Deuteration of CaM was achieved by
growing cells in ModC1 minimal media (29) containing 90% D2O (v/v)
with nondeuterated glycerol (40 g/L) as the carbon source to yield CaM
with 73% of nonexchangeable hydrogens deuterated, as determined by
partial trypsin digest MALDI-TOF mass spectrometry.
Complexes of CaM-MAwere formed under conditions previously deter-
mined in Chow et al. (27) by mixing a 1:1 molar ratio of CaM and MA and
dialyzing into buffers containing 50 mMMOPS pH 7.0, 5 mMCaCl2, 2 mM
tris(2-carboxyethyl)phosphine hydrochloride (TCEP). A range of H2O/D2O
ratios were used to yield samples for neutron scattering in 19%, 44%,
88%, and 100% v/v D2O with protein concentrations of 7.7, 7.0, 7.4, and
7.5 mg/mL, respectively. All protein concentrations were determined by
UV absorbance (calculated molar extinction coefficients for CaM and
MA were ε276 nm ¼ 3030 M1 cm1 and ε280 nm ¼ 17,085 M1 cm1,
respectively (27)). The equilibrated dialysates were used as matched
solvent blanks for the neutron scattering experiments. The final percentage
of D2O for each equilibrated dialysate was checked by densitometry (DMA
5000 Density Meter; Anton-Paar, Ashland, VA). For each SANS measure-
ment, 300 mL of protein solution or solvent blank was loaded into a 1-mm
path-length, banjo-shaped cell (product No. 120-1 mm; HELLMA USA,
Plainview, NY). Small-angle x-ray scattering (SAXS) measurements wereBiophysical Journal 103(3) 541–549made in a 2-mm glass capillary cell. Further details of sample preparation
are provided in the Supporting Material.Small-angle scattering data acquisition and
reduction
Neutron scattering
SANS data were acquired using the SANS instrument Quokka at the
Australian Nuclear Science and Technology Organisation (30,31) using
a wavelength, l, of 4.94 A˚ (Dl/l of 6.65%) with the sample holder main-
tained in the range 10–20C. Data were acquired for the attenuated direct
beam sample and matched solvent transmissions and scattering, and empty
cell and blocked beam with sample-to-detector positions suitable to give
a measured q-range 0.007–0.3 A˚1.
Data for each sample measured at different detector positions were
combined and reduced to I(q) versus q (q ¼ (4psinq)/l, 2q is the scattering
angle) using IGOR Pro 6.1 (WaveMetrics, Portland, OR) with Quokka data
reduction macros installed (32). Detector sensitivity corrections were
applied using the H2O or 19% D2O solvent scattering. Radially averaged
I(q) versus q for each measurement was obtained (before combination of
data from different detector setting) after subtracting the scattering due to
the empty cell and blocked beam with corrections for sample and buffer
transmissions. The data were put on an absolute scale by reference to the
measured beam flux. The scattering due to the protein was obtained by
subtraction of the solvent scattering from that of the protein-plus-solvent
sample.
X-ray scattering
SAXS data were acquired using the Nanostar instrument (Bruker AXS,
Madison, WI) at the Australian Nuclear Science and Technology Organisa-
tion. Samples were maintained at 10C during measurement. The scattering
data were reduced to I(q) versus q using the program ‘‘SAXS: Small Angle
X-Ray Scattering System V4.1.29’’, which circularly averages the raw data
and corrects for detector sensitivity and nonlinearity. All data were placed
on an absolute scale using the scattering of water as a standard (33) and the
scattering due to the protein was obtained by subtraction of the solvent-
plus-cell scattering from that of the protein-plus-solvent-plus cell.Small-angle scattering data analysis and
molecular modeling
All scattering data analysis and modeling used programs of the ATSAS
program package (34). Guinier analyses used PRIMUS to yield estimates
of the intensity at zero scattering angle, I(0), and radius of gyration, Rg.
GNOM was used to determine P(r) versus r and the associated I(0) and
Rg values. Determination of the molecular mass, Mr, of the CaM-MA
complex in solution used the SAXS-determined zero-angle scattering I(0)
value (0.2 cm1) and the method of Orthaber et al. (33) (see the Supporting
Material) with values for the protein contrast (3.084  1010 cm2) and
partial specific volume (0.727 cm3 g1) determined using the amino-acid
sequences and the program MULCh (35).
Ab initio shape modeling was performed using the combined SAXS and
SANS data and the multiphase dummy-atom modeling program MONSA
in the slow mode with P1 symmetry and default parameters. Rigid body
modeling (detailed in the SupportingMaterial) used the program SASREF7.
The programsCRYSOL or CRYSONwere used to calculate SAXS or SANS
profiles, respectively, from Protein Data Bank (PDB) structures.Nuclear magnetic resonance spectroscopy
MA and CaM were expressed and purified as above, except CaM pro-
duction was from H2O media and
15N-labeled MA was produced using
CaM Binds a Highly Extended MA Protein 543M9minimal growth medium with 15NH4Cl as the sole nitrogen source (27).
15N-MA and unlabeled CaM were dialyzed into a buffer containing 10 mM
sodium phosphate (pH 5.5), 5 mM CaCl2 and 1 mM TCEP. The CaM-MA
complex was formed as above by mixing a 1:1 molar ratio of 15N-MA and
CaM with excess Ca2þ in the solvent. For the KCl titration experiments,
a final concentration range from 0–500 mM was investigated, and for the
EGTA titration, a final concentration range of 0–10 mM was investigated.
For each titration of KCl or EGTA into solutions initially containing the
CaM-MA complex, the sample was allowed to equilibrate for a minimum
of 10 min after each addition before NMR spectra were recorded. Spectra
for denatured 15N-labeled MA were collected after dialysis of the sample
into the above buffer that additionally contained 6 M guanidinium HCl.
All two-dimensional 1H-15N-HSQC spectra were recorded at 298 K
(25C) using an Avance III 600- or 800-MHz spectrometer (Bruker)
equipped with a triple resonance cryogenic TCI probe. NMR data were pro-
cessed with the program TOPSPIN (Bruker) and analyzed with SPARKY
(T. D. Goddard and D. G. Kneller, University of California, San Francisco).
Previously published NMR 1H-15N chemical shift assignments for MA
(BMRB #7250) were used to assign the 1H-15N HSQC spectrum of
15N-MA.RESULTS
SANS data, I(q) versus q, for the CaM-MA complex in solu-
tions prepared with 19%, 44%, 88%, and 100% v/v D2O
along with SAXS data for the complex are shown in Fig. 1 a
with corresponding, P(r) versus r profiles in Fig. 1 b. All the
scattering data are for calcium-saturated CaM (73% deuter-
ated) complexed with nondeuterated MA, which we denote
here simply as CaM-MA.
Guinier plots for each SANS and SAXS profile (see
Fig. S1 a in the Supporting Material) show the expected
linearity for a solution of monodisperse scattering particles
and the SAXS data are consistent with the expected results
for the complex. The molecular mass calculated from the
SAXS data is 34,500 Da (see Materials and Methods),
which is within experimental uncertainty (<10%) of that ex-
pected for the 1:1 CaM-MA complex based on amino-acid
sequence (31,700 Da). The Rg and Dmax values determinedFIGURE 1 Scattering data for CaM-MA. (a) I(q) versus q and (b) P(r)
versus r. Symbol key: SAXS data (,), and SANS data for CaM-MA in
19% D2O (B), 44% D2O (6), 88% (7), and 100% D2O (>). The solid
lines in a are the fits of theMONSA-derivedmodel in Fig. 3. The I(q) profiles
have been offset on the vertical scale for clarity. The P(r) profiles are on
a relative scale that accounts for the contrast of each scattering profile.from the SAXS data for the complex with deuterated CaM
(31.4 A˚ and 110 A˚, respectively, Table 1) are in reasonable
agreement with those obtained previously for the complex
formed with nondeuterated CaM (30.5 A˚ and 110 A˚, respec-
tively) (27). A plot of the square-root of I(0) as a function of
% D2O in the solvent (Fig. S1 b) has the expected linear
dependence with an intercept on the D2O axis that predicts
the average scattering density for the complex is matched to
that of the solvent at 75% D2O. This value is in excellent
agreement with that expected from chemical and isotopic
composition (74.6%, calculated based on the amino-acid
sequence using MULCh (35).)
The P(r) profiles represent the probable distribution of
pairwise distances between atoms within the scattering
particle weighted by the product of the contrast values at
their positions (r); hence, P(r) goes to zero at the maximum
linear dimension of the particle, Dmax. In the SAXS exper-
iment the complex is an approximately uniform scattering
density object and the P(r) profile is as expected from
our previous studies (27). On the other hand, the P(r) pro-
files calculated from the SANS data show the anticipated
variations with percent D2O due to the changing con-
trast values that give rise to the large changes in effec-
tive I(0) and Rg values observed in the Guinier analyses
(Table 1).CaM within the CaM-MA complex adopts
a semiextended conformation
In ~44% D2O, the scattering density of MA in the CaM-MA
complex was calculated to match the solvent and therefore
was expected to not contribute significantly to the SANS
data. If the solvent matching is sufficiently good, these
data would yield the structural parameters for CaM within
the complex. To test the effectiveness of the solvent match-
ing, the molecular mass of the scattering particle for these
data were determined using Kratky analysis. The volume
and corresponding molecular mass, Mr, value obtained
was 16,400 Da (using the correction factors from Fisher
et al. (36) to account for the finite q-range measured), inTABLE 1 SAXS and SANS contrast series parameters for
CaM-MA
Dr* (cm2) Rg
y (A˚) Rg
z (A˚) Dmax
z (A˚)
SAXS 3.084  1010 30.95 0.2 31.45 0.3 110
SANS 19%
D2O
3.035  1010 29.75 1.3 30.05 0.8 105
SANS 44%
D2O
1.700  1010 20.95 1.3 20.75 1.0 64
SANS 88%
D2O
0.858  1010 13 5 1 13.35 0.9 43
SANS 100%
D2O
1.414  1010 41 5 6 415 2 110
*Values of Dr calculated using MULCh (35).
yRg determined from Guinier analysis and data for which qRg < 1.3.
zRg and Dmax determined from P(r) analysis.
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FIGURE 2 Comparisons of CaM in CaM-MA with CaM-peptide struc-
tures. (a) 44% D2O I(q) versus q for CaM-MA (6) with CRYSON fits of
the crystal structures of CaM (PDB:1CLL) (dotted line), and CaM taken
from its structures in its complexes with Munc13 (PDB:2KDU) (solid
line) and skMLCK (PDB:2BBM) (dashed line). (b) P(r) versus r for the
experimental and modeled profiles shown in panel a using the same key.
544 Taylor et al.excellent agreement with the expected 16,700 Da based on
amino-acid sequence.
The Guinier- and P(r)-derived Rg values from the 44%
D2O data (20.9 5 1.3 A˚ and 20.7 5 1.0 A˚, respectively)
are in excellent agreement with each other, and lie in
between the values expected for the fully extended dumbbell
shape of the crystal structure (23 A˚, from CRYSOL calcula-
tion with PDB:1CLL) and the compact version of CaM
when complexed with the classical helical binding target
skeletal muscle myosin light chain kinase (skMLCK,
Rg ~17 A˚ from both SANS data (37) and the NMR structure
(22)). The P(r) determined from the 44%D2O data (Fig. 1 b)
also has an asymmetric shape with a peak at ~20 A˚ and
a Dmax of 64 A˚, characteristic of a mostly, but not fully
extended, dumbbell-shaped CaM.
Our previous investigations (27) and those of Ghanam
et al. (28) have shown that the tryptophans in MA, W16,
and W36, interact directly with CaM in the hydrophobic
clefts of each CaM lobe indicating bidentate-like binding
of CaM to MA. Recently, the NMR structure of CaM bound
to its target sequence in Munc13 has been determined
(38,39). The structure reveals that the hydrophobic cleft in
each Ca2þ-binding lobe of CaM binds one of two trypto-
phans that, like the CaM-binding tryptophans in MA, are
widely separated in sequence (by 24 amino acids in
Munc13 compared to 19 in MA.) This binding facilitates
CaM adopting a semiextended conformation with the
Munc13 peptide, although in this complex it appears that,
as for uncomplexed CaM in solution, there is flexibility in
CaM’s interconnecting helix region. We compared the scat-
tering profile for CaM in the CaM-MA complex with that
of a semiextended CaM in its complex with the Munc13
peptide and that of the classical collapsed CaM binding
mode induced by shorter helical target sequences. Note
that the latter typically contain one tryptophan and an addi-
tional large hydrophobic residue spaced by 12 amino acids
(as in skMLCK (22).
The Rg value of CaM in the complex with MA is within
experimental error of that calculated for the semiextended
CaM from the CaM-Munc13 peptide complex (20.7 5
1.0 A˚, coordinates taken from the first structure in the
NMR ensemble in PDB:2KDU; compare to ~21 A˚, Table 1).
The predicted scattering profile calculated from the atomic
coordinates of the semiextended CaM also provides an
overall superior fit to the 44% D2O data (c ¼ 0.5) when
compared to either the fully extended CaM structure
(PDB:1CLL, c ¼ 0.6) or the collapsed form observed on
binding to a skMLCK peptide (PDB:2BBM (CaM), c ¼
0.7) (Fig. 2 a). The c-values for these fits are all <1, indi-
cating the propagated statistical errors are an overestimate
of the errors in the scattering data for fitting a smooth func-
tion. Nonetheless, consistent with the trends in c, visual
inspection of the fits affirms that the semiextended CaM is
superior; discrepancies in the fits of the fully extended or
collapsed conformations of CaM to the SANS data areBiophysical Journal 103(3) 541–549evident in the mid-to-high q-region (>0.1 A˚1) that is
most impacted by the spatial disposition of the globular
lobes. Further, the expected differences are observed in
the P(r) profiles for these different degrees of CaM exten-
sion (Fig. 2 b). It thus appears that the CaM lobes reorient
in such a way that, when engaging with W16 and W36 of
MA, the overall conformation of CaM adopts a semiex-
tended binding mode very similar to that observed in the
CaM-Munc13 ensemble.
The solvent-matching strategy that allowed for the anal-
ysis of the CaM structural parameters was not applicable
to the MA component of the complex because the theoret-
ical solvent match point for the 73% deuterated CaM was
somewhat greater than 100% D2O. The alternate strategy
of developing a shape model for the complex, however,
provides information about the MA structure and its dispo-
sition with respect to CaM in the complex.The semiextended CaM binds a highly extended
MA in an open-clamp conformation
The multiphase bead modeling method (MONSA, see
Materials and Methods) was used to simultaneously fit the
full set of contrast variation data (SANS and SAXS) and
produce a shape model for the CaM-MA complex (Fig. 3).
The modeling calculations were repeated six times and fits
to the experimental data indicate good agreement, within
the propagated statistical errors (Fig. 1 a; c-values for the
fits shown are 1.0, 0.6, 1.0, 0.9, 1.0 for the 19%, 44%,
88%, 100% D2O SANS and SAXS data, respectively;
Table S1 in the Supporting Material gives c-values for fits
from all six calculations, each of which yielded models
with the same features). We note the relatively poor fit of
the MONSA model to the lowest-q region (<0.03 A˚1) of
the 88% D2O SANS data. This effect is attributable to the
fact that the MONSA model assumes the CaM and MA
FIGURE 3 MONSA-derived shape model for CaM-MA.
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contrast points close to the solvent match point of a compo-
nent, internal density fluctuations become significant. For
the 88% D2O data, the CAM-MA has very low con-
trast and the assumption of uniform density starts to break
down.
CaM in the MONSA model has an Rg of 20 A˚ and Dmax
equal to ~64 A˚ in good agreement, within experimental
error, with the values determined by Guinier or P(r) from
the 44% D2O SANS data. For the MA in the MONSA
model, the Rg value is 36 A˚, which is significantly greater
that the value for the complex as a whole, and its Dmax is
equal to that of the complex and ~70% greater than that
for CaM. In comparison, the Rg and Dmax values for free
MA in solution measured by SAXS (Rg ¼ 19.9, Dmax ¼
70 A˚) (30) indicate a much more compact structure consis-
tent with the crystal (24) and NMR (25) structures that show
a globular N-terminal domain with an unstructured or disor-
dered C-terminal tail. This result is consistent with earlier
evidence that CaM-MA complex formation is accompanied
by a dramatic loss of tertiary contacts within MA (27,28).
The MONSA model for the CaM-MA complex shows an
extended complex with one dimension significantly longer
that the other two. CaM has a semiextended dumbbell shape
and binds toward one end of the relatively narrow, bent, and
highly extended MA. There appear to be extensive contacts
between CaM and MA as their longest dimensions are
approximately aligned such that the full length of the semi-
extended CaM spans 70% of the length of MA.Dissociation of the CaM-MA complex results in
restoration of the native, uncomplexed MA
structure
The two-dimensional 1H-15N-HSQC spectra recorded for
15N-MA free and in complex with unlabeled CaM are
very similar to previously published spectra recorded for
myristoylated (28) or unmyristoylated (25) MA. In partic-
ular, many peaks in the MA spectrum disappeared or
moved to the region of the spectrum typically associatedwith less structured residues upon binding to CaM
(Fig. 4, a and b), consistent with the loss of tertiary contacts
that would be expected for MA to form the narrow and
highly elongated structure as characterized in the SANS
experiment on the complex. Our previous studies indicated
that this loss of tertiary contacts is associated with only
some loss of the predominantly helical structure in MA
(circular dichroism data indicate free MA has 53 5 3%
helical structure compared to an estimated 41 5 2% in
the complex (27)).
To test whether the unfolding of MA upon binding to
CaM is reversible, the complex was titrated with either the
Ca2þ-chelator EGTA (0–10 mM) or by increasing ionic
strength of the solution (KCl, 0–500 mM). EGTA is known
to remove Ca2þ from CaM at mM concentrations with
a resultant closure of the hydrophobic clefts in each of the
globular lobes that are key to target recognition and binding.
KCl additions were chosen, as we have reported previously
that increasing salt concentrations decreases the strength of
the CaM-MA interaction (27). With increasing KCl, there is
a gradual return of the 15N-HSQC spectrum to that observed
for free 15N-MAwith a large proportion of peaks reappear-
ing at 500 mM KCl (Fig. 4 c). A similar result was obtained
upon addition of EGTA (Fig. 4 d).
To ascertain the degree of MA unfolding by CaM, a two-
dimensional 1H-15N-HSQC spectrum of 15N-MA in 6 M
guanidine hydrochloride (GuHCl) (Fig. 4 e) was compared
to that recorded on 15N-MA complexed with CaM (no
salt). The comparison reveals a distinct pattern of unfolding
for these two conditions (Fig. 4, b and e). The GuHCl-
induced unfolding appears to be more complete as the
HSQC spectrum for this condition displays many more
sharp peaks when compared with the spectrum for the
CaM-MA complex. In both cases, all observable peaks
show little dispersion and are located in the region of the
spectrum associated with unstructured and solvent exposed
residues. The spectral features are consistent with the fact
that the previous circular dichroism data indicate that MA
bound to CaM appears to retain a significant portion of its
helical structure (27). Upon redialysis into a buffer without
GuHCl, MA again was able to adopt its original conforma-
tion (Fig. 4 f).
As observed previously in Chow et al. (27), signals for the
indole rings of both tryptophan residues (W16 and W36),
disappear when MA is bound to CaM. Upon dissociation of
MA from CaM, either by addition of KCl or EGTA, the
peak corresponding to at least one tryptophan residue in
MA (W16) returns to its original peak position. The NMR
data indicate that in the presence of 500 mM KCl or
10 mM EGTA, some MA remains in complex with CaM.
This result is consistent with previous tryptophan fluores-
cence titration results that indicatedweak and similar binding
constants in either 500 mM KCl or 10 mM EGTA (approxi-
mately mM compared to the Kd of ~170 nM determined in
the presence of saturating Ca2þ and low salt (27)).Biophysical Journal 103(3) 541–549
FIGURE 4 Two-dimensional 15N-1H-HSQC spectra from CaM-MA. (a) 15N-MA only; (b) 15N-MA-CaM complex in 10 mM NaPO4 (pH 5.5), 5 mM
CaCl2, 1 mM TCEP; (c and d) the
15N-MA-CaM complex after titration with either KCl (to 500 mM) or EGTA (10 mM), respectively, showing many peaks
corresponding to folded MA have been restored; (e) 15N-MA in 6 M GuHCl, and (f) 15N-MA after removal of 6 M GuHCl.
546 Taylor et al.DISCUSSION AND CONCLUSIONS
The contrast variation experiments described here take
advantage of the different x-ray and neutron scattering prop-
erties of hydrogen and deuterium to reveal, to our knowl-
edge for the first time, the shapes and dispositions of the
CaM and MA components in the CaM-MA complex. ABiophysical Journal 103(3) 541–549schematic representation of the CaM-MA complex derived
from all of the available structural evidence is presented
in Fig. 5 (see the Supporting Material and Fig. S2 for details
of the construction of the schematic model). The scattering
data show CaM adopts an overall semiextended conforma-
tion that can be described as an open-clamp that structurally
FIGURE 5 Schematic of CaM-MA interaction. In the presence of Ca2þ
and at low ionic strength, CaM binds MA in an open-clamp, semiextended
bidentate conformation resulting in a dramatic extension of MA. Release of
MA, which can be induced either by increasing ionic strength or loss of
Ca2þ, results in reformation of the native, free MA structure.
CaM Binds a Highly Extended MA Protein 547disrupts the tertiary fold of MA as it undergoes a dramatic
structural extension due to the loss of its native tertiary
contacts. The MA protein within the CaM-MA complex
appears as a long snakelike shape with no evident globular
domain that bears any similarity to that observed in its un-
complexed state.
It appears that MA retains a significant proportion of its
helical structure upon CaM binding, which would be in
line with CaM-binding sequences generally. Furthermore,
based on our NMR data, modulations in Ca2þ concentration
and/or ionic strength alter the degree of CaM-MA associa-
tion and MA displays an inherent structural pliancy that
facilitates the protein spontaneously refolding to its native
structure upon disassociation from CaM. Consequently,
these two small proteins constitute a structurally dynamic
system that is sensitive to alterations in environmental
conditions. By inference, the formation or disassociation
of the CaM-MA complex could be modulated by Ca2þ
signaling pathways within a cell.
In the structure of uncomplexed MA (25,26), the trypto-
phans W16 andW36 are positioned in the first two a-helices
(a1, a2) of the MA globular domain that are linked by
a long, basic b-turn-b motif (residues 17–31) that results
in an approximately perpendicular arrangement of a1 with
respect to a2 with only a 10–15 A˚ spacing between the
tryptophans (see Fig. S3). These two helices are key
structural elements in forming the hydrophobic core of
free MA (25,26). The indole ring of W16 is deeply buried
within the hydrophobic core that also accommodates the
N-terminal myristoyl group (28). One face of the W36
indole ring packs against the hydrophobic core whereasthe other face forms part of a highly conserved surface/
solvent-exposed cleft that accepts PI(4,5)P2.
The basic b-turn-b motif also forms part of the PI(4,5)P2
binding pocket (16). The binding of CaM to MAvia interac-
tions with W16 and W36 is thus expected to significantly
perturb the interactions that stabilize the MA hydrophobic
core. The dramatic extension evident from the SANS data
implies a concomitant reorientation of a1 relative to a2
either by distorting or completely disrupting the b-turn-b
motif so that the tryptophans can interact with the hydro-
phobic clefts in the two separated CaM lobes (requiring
an ~40 A˚ separation distance for the tryptophans). The
consequent impacts on the entire tertiary fold of MA, as
observed in our NMR data, are dramatic. The disruption
to the hydrophobic core and the topology of the W36/b-
turn-b surface cleft are expected to have significant conse-
quences on both myristoylate exposure and PI(4,5)P2
binding (the two key features of MA that facilitate Gag-
localization to the plasma membrane). Intriguingly, the
reverse process may also be affected, i.e., the release of
MA from the matrix into the cytoplasm on viral fusion
with the plasma membrane.
The amino-acid sequence between the first and second
tryptophans of MA (that includes the positively charged
b-turn-b element with the consensus sequence K(V/I)
RLRP(X)GKK(X)Y(X)L) could be important for maintain-
ing the extended conformation of CaM. This very short
basic region of MA has been implicated in PI(4,5)P2 binding
(16) as well as RNA (14) and DNA (40) binding, Gag pro-
cessing (41), and Env incorporation (42,43). The 19-amino-
acid spacing between the two tryptophans in HIV-1 MA is
fixed across HIV1, HIV2, and simian immunodeficiency
virus although the first tryptophan at position 16 can be
substituted for other hydrophobic residues including L, F,
and Y. The physical constraint of having two widely spaced
interaction sites for CaM binding, that to date has only been
superseded by the 24-amino-acid spacer of Munc13, would
in itself help CaM to clamp to MA in an extended conforma-
tion. It is interesting to note that SAXS (10) and NMR (44)
data acquired from CaM-MA peptide complexes with
sequence segments from MA that contain only one of the
two CaM-binding tryptophans reveal two distinct CaM
binding modes. Peptides containing W16 bind CaM in an
extended conformation whereas peptides containing W36
bind CaM in its collapsed conformation similar to the clas-
sical binding mode originally observed for skMLCK (22).
In both cases, the tryptophan (either W16 or W36) inter-
acts with the C-terminal lobe of CaM. We therefore hypoth-
esize that the identity of amino acids directly upstream of
the first CaM binding site in MA (position 16) is important
in facilitating the extended CaM conformation that we
observe in the CaM-MA complex. The inclusion of the
K(V/I)RLRP(X)G consensus sequence of alternating hydro-
phobic and charged residues of the b-turn-b element
upstream from W16 could allow MA to interact with theBiophysical Journal 103(3) 541–549
548 Taylor et al.C-terminal domain of CaM in such a way as to correctly
orient the N-terminal lobe for an interaction with the
more-distant distant W36. At the same time a perturbation
in the b-turn-b region that causes the angle between a1
and a2 to open could ultimately unravel MA as indicated
by our scattering and NMR data.
There have been differing interpretations published con-
cerning the nature of the stabilizing interactions in the
CaM-MA complex. Our combined studies, as well as those
of Izumi et al. (45), indicate that interactions with the CaM
hydrophobic clefts and the tryptophans of MA as well as
ionic interactions play a role in the interaction between
the two proteins. Others have concluded that ionic interac-
tions are not significant (28). For our SAXS and SANS
studies, the CaM-MA complex could only be isolated in
pure form (by size exclusion chromatography) and in suffi-
cient quantities using very low ionic-strength solution con-
ditions. Our pull-down assays (that are affected by
successive rounds of washing) indicate that the complex
has an increased propensity to dissociate at higher ionic
strength. Our NMR data also show evidence for increased
MA dissociation from CaM with increasing KCl concentra-
tions, although even at 500 mM KCl there is some residual
complex. Our combined observations, thus, are consistent
with ionic interactions playing a significant role in the
formation of the complex. It is interesting to speculate as
to whether this dependence might have some biological
relevance, given the changes in potassium and sodium levels
over the course of the HIV infection cycle (46).SUPPORTING MATERIAL
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